Dr. Roach: Fatigue and tingling persist amid treatment for anemia
I am 71 years old and was diagnosed with pernicious anemia in October 2024. My B12 and folate levels were low. My antiparietal antibodies were abnormal, but the ...
Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
The American Journal of Managed Care1d
FDA Approves Ranibizumab Implant in Treatment of DME
The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...
Third Energy Innovation Signaling A Golden Age: Enhanced Geothermal
Advantages of EGS are high capacity, low carbon emissions, small land footprint, and flexibility to back up intermittent ...
Will This New GLP-1 Drug be More Powerful Than Ozempic?
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
News Medical1h
Biden rule cleared hurdles To lifesaving HIV drug, but in Georgia barriers remain
Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has faced repeated challenges getting the lifesaving drug that can prevent new HIV ...
stocknews2d
3 Genomic Stocks at the Forefront of Precision Medicine
Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...
Brandnew Clinic Celebrates 15Th Anniversary With Exclusive Promotions And Events
Brandnew clinic Celebrates 15th Anniversary with Exclusive Promotions and Events "15 Years of Trust, Innovation, and Customer Appreciation Promotions" Cheongdam-dong Dermatology Brandnew Clinic, ...
PharmiWeb1d
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...
Flagstar Financial: A Speculative Prospect That's Not For The Faint Of Heart
Flagstar Financial’s turnaround efforts drive a 15.2% surge. Read why FLG stock is a speculative buy with potential for ...
Zacks.com on MSN20h
JBL Boosts Healthcare Portfolio With Strategic Buyout: Stock to Gain?
Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.
Healthbeat on MSN2h
Georgia leads in U.S. HIV cases. Here’s why the lifesaving drug PrEP faces barriers in the state.
A rule enacted by the Biden administration that took effect for many Affordable Care Act plans on Jan. 1 should make it ...